Literature DB >> 22574797

Dose-independent kinetics with low level exposure to nicotine and cotinine.

Neal L Benowitz, Delia Dempsey, Rachel F Tyndale, Gideon St Helen, Peyton Jacob.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 22574797      PMCID： PMC3555070          DOI： 10.1111/j.1365-2125.2012.04327.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN： 0306-5251            Impact factor:   4.335


× No keyword cloud information.
  12 in total

Review 1.  Genetic variation in CYP2A6-mediated nicotine metabolism alters smoking behavior.

Authors:  Rachel F Tyndale; Edward M Sellers
Journal:  Ther Drug Monit       Date:  2002-02       Impact factor: 3.681

2.  CYP2A6 genotype and the metabolism and disposition kinetics of nicotine.

Authors:  Neal L Benowitz; Gary E Swan; Peyton Jacob; Christina N Lessov-Schlaggar; Rachel F Tyndale
Journal:  Clin Pharmacol Ther       Date:  2006-11       Impact factor: 6.875

Review 3.  Cotinine as a biomarker of environmental tobacco smoke exposure.

Authors:  N L Benowitz
Journal:  Epidemiol Rev       Date:  1996       Impact factor: 6.222

4.  Elimination of cotinine from body fluids: disposition in smokers and nonsmokers.

Authors:  N J Haley; D W Sepkovic; D Hoffmann
Journal:  Am J Public Health       Date:  1989-08       Impact factor: 9.308

5.  Ethnic variation in CYP2A6*7, CYP2A6*8 and CYP2A6*10 as assessed with a novel haplotyping method.

Authors:  Jill C Mwenifumbo; Mark G Myers; Tamara L Wall; Shih-Ku Lin; Edward M Sellers; Rachel F Tyndale
Journal:  Pharmacogenet Genomics       Date:  2005-03       Impact factor: 2.089

Review 6.  Metabolism and disposition kinetics of nicotine.

Authors:  Janne Hukkanen; Peyton Jacob; Neal L Benowitz
Journal:  Pharmacol Rev       Date:  2005-03       Impact factor: 25.468

Review 7.  Molecular genetics of nicotine metabolism.

Authors:  Jill C Mwenifumbo; Rachel F Tyndale
Journal:  Handb Exp Pharmacol       Date:  2009

8.  Association of nicotine metabolite ratio and CYP2A6 genotype with smoking cessation treatment in African-American light smokers.

Authors:  M K Ho; J C Mwenifumbo; N Al Koudsi; K S Okuyemi; J S Ahluwalia; N L Benowitz; R F Tyndale
Journal:  Clin Pharmacol Ther       Date:  2009-03-11       Impact factor: 6.875

9.  Selected ion monitoring method for determination of nicotine, cotinine and deuterium-labeled analogs: absence of an isotope effect in the clearance of (S)-nicotine-3',3'-d2 in humans.

Authors:  P Jacob; L Yu; M Wilson; N L Benowitz
Journal:  Biol Mass Spectrom       Date:  1991-05

10.  Nicotine and cotinine elimination pharmacokinetics in smokers and nonsmokers.

Authors:  N L Benowitz; P Jacob
Journal:  Clin Pharmacol Ther       Date:  1993-03       Impact factor: 6.875
View more
  1 in total

1.  CYP2A6 Effects on Subjective Reactions to Initial Smoking Attempt.

Authors:  Dale S Cannon; Robin J Mermelstein; Tait R Medina; Oksana Pugach; Donald Hedeker; Robert B Weiss
Journal:  Nicotine Tob Res       Date:  2015-11-05       Impact factor: 4.244
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.